Mark Mallon
2020
In 2020, Mark Mallon earned a total compensation of $6.8M as Former Chief Executive Officer at Ironwood Pharmaceuticals, a 32% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $585,169 |
|---|---|
| Salary | $801,173 |
| Stock Awards | $5,423,731 |
| Other | $11,040 |
| Total | $6,821,113 |
Mallon received $5.4M in stock awards, accounting for 80% of the total pay in 2020.
Mallon also received $585.2K in non-equity incentive plan, $801.2K in salary and $11K in other compensation.
Rankings
In 2020, Mark Mallon's compensation ranked 1,444th out of 13,090 executives tracked by ExecPay. In other words, Mallon earned more than 89.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,444 out of 13,090 | 89th |
Division Manufacturing | 534 out of 5,624 | 91st |
Major group Chemicals And Allied Products | 192 out of 2,257 | 92nd |
Industry group Drugs | 163 out of 1,957 | 92nd |
Industry Pharmaceutical Preparations | 113 out of 1,462 | 92nd |
Pay ratio
| Mark Mallon's Pay | $6,821,113 |
|---|---|
| Median Employee's Pay | $222,011 |
| Pay Ratio | 31to 1 |
In 2020, the annual total compensation of Mark Mallon was $6,821,113.
The annual total compensation of the median employee at Ironwood Pharmaceuticals was $222,011.
The ratio of Mark Mallon's pay to the pay of median employee was therefore 31 to one.
Source: SEC filing on April 22, 2021.
Mallon's colleagues
We found four more compensation records of executives who worked with Mark Mallon at Ironwood Pharmaceuticals in 2020.